The stock has experienced significant volatility over the past six months, with a clear downtrend from a peak near $550 in early February 2026 to a current price of $444.4. The 1-month and 3-month price changes are -5.47% and -9.37%, respectively, underperforming the broader market as indicated by negative relative strength figures of -0.22 and -4.74 against the S&P 500.

The current price of $444.4 sits near the lower end of its 52-week range of $396.14 to $550.18, representing a decline of approximately 19.2% from its high. The stock's beta of 1.27 suggests it is more volatile than the market, which has been evident in its recent price swings.

While specific RSI data is not provided, the price action shows a sharp correction from February highs, followed by a period of consolidation at lower levels in March. The stock remains above its 52-week low but is significantly off its highs, indicating a bearish intermediate-term trend.

Revenue for Q4 2025 was $5.05 billion, showing an 8.26% year-over-year growth from the same quarter in 2024. Net income for the quarter was $1.01 billion, resulting in a healthy net margin of 19.97%. Profitability metrics are strong, with a trailing ROE of 54.4% and an operating margin of 25.54%.

The company maintains a solid financial position with a debt-to-equity ratio of 0.90, indicating moderate leverage. The current ratio is exceptionally high at 7.87, suggesting strong short-term liquidity. Free cash flow over the trailing twelve months is a robust $2.89 billion.

Operational efficiency is highlighted by the high return on equity of 54.4%. The company's asset turnover, while not explicitly provided in the key metrics, can be inferred from the high ROE and moderate leverage, suggesting effective use of its asset base to generate profits.